Partnering & Licensing

Myriad Genetics develops both unique molecular diagnostic assays and novel therapeutics.

Our Molecular Diagnostic and R&D units are very interested in opportunities involving personalized medicine and predictive medicine, including the fields of oncology and neuroscience, and other biomarker development-discovery areas. Myriad‘s Therapeutic division actively develops therapeutics with a disease focus in the fields of oncology, virology and neurodegeneration.

We have a strong commitment to being a leader in our business and understand the value of building strong partnerships with other leading companies and laboratories to accomplish this strategic goal.

Myriad welcomes the chance to review details of a prospective, mutual opportunity within our areas of interest. Please contact us for more information about the business development opportunities described throughout this site, or to schedule an initial phone call or meeting.

Provision of non-confidential information concerning your technology or product, complete contact information and an overview summary about your institution is most appreciated.

The Myriad Genetics Business Development Team looks forward to hearing from you.

Therapeutics

Patrick Burke, PhD
Senior Director, Business Development
Myriad Pharmaceuticals, Inc.
pmburke@myriad.com
(801) 584-3766

Research and Development

John Gill, JD, MBA
Senior Director, Business Development
Myriad Genetics, Inc.
jgill@myriad.com
(801) 584-6513

Molecular Diagnostics

Mike Hansen, PhD, MBA
VP, Business Development
Myriad Genetic Laboratories, Inc.
mihansen@myriad.com
(801) 505-5065